logo
The smoke from Canada's wildfires may be even more toxic than usual

The smoke from Canada's wildfires may be even more toxic than usual

This story was originally published by Grist and appears here as part of the Climate Desk collaboration
More than 200 wildfires are blazing across central and western Canada, half of which are out of control because they're so hard for crews to access, forcing 27,000 people to evacuate. Even those nowhere near the wildfires are suffering as smoke swirls around Canada and wafts south, creating hazardous air quality all over the midwestern and eastern parts of the United States. The smoke is even reaching Europe.
As the climate changes, the far north is drying and warming, which means wildfires are getting bigger and more intense. The area burned in Canada is now the second largest on record for this time of year, trailing behind the brutal wildfire season of 2023. That year, the amount of carbon blazed into the atmosphere was about three times the country's fossil fuel emissions. And the more carbon that's emitted from wildfires — in Canada and elsewhere — the faster the planetary warming, and the worse the fires.
'There's obviously the climate feedback concern,' said Mike Waddington, an environmental scientist at McMaster University in Ontario who studies Canada's forests. 'But increasingly we're also concerned about the smoke.'
That's because there's much more to wildfire smoke than charred sticks and leaves, especially where these blazes are burning in Canada. The country's forests have long been mined, operations that loaded soils and waterways with toxic metals like lead and mercury, especially before clean-air standards kicked in 50 years ago. Now everyone downwind of these wildfires may have to contend with that legacy and those pollutants, in addition to all the other nasties inherent in wildfire smoke, which are known to exacerbate respiratory and cardiac problems.
'You have there the burning of these organic soils resulting in a lot of carbon and a lot of particulate matter,' said Waddington. 'Now you have this triple whammy, where you have the metals remobilized in addition to that.'
What exactly is lurking in the smoke from Canadian wildfires will require further testing by scientists. But an area of particular concern is around the mining city of Flin Flon, in Manitoba, which is known to have elevated levels of toxic metals in the landscape, said Colin McCarter, an environmental scientist who studies pollutants at Ontario's Nipissing University. Flin Flon's 5,000 residents have been evacuated as a wildfire approaches, though so far no structures have been destroyed.
The smoke from Canada's wildfires may be even more toxic than usual. #Wildfires #WildfireSmoke
But a fire doesn't need to directly burn mining operations to mobilize toxicants. For example, in Yellowknife, in Canada's Northwest Territories, gold mining operations between 1934 and 2004 spread arsenic as far as 18 miles away, adding to a landscape with an already high concentration of naturally occurring arsenic. In a paper published last year, Waddington and McCarter estimated that between 1972 and 2023, wildfires around Yellowknife fired up to 840,000 pounds of arsenic into the atmosphere. Arsenic is a known carcinogen associated with cardiovascular disease, diabetes, and developmental problems, according to the World Health Organization. (After the 2023 Lahaina fire in Maui, officials reported elevated levels of arsenic, lead, and other toxic substances in ash samples. California officials also found lots of lead in smoke from 2018's Camp Fire.)
Within wildfire smoke is also PM 2.5, particulate matter smaller than 2.5 microns (a millionth of a meter) that gets deep inside human lungs. This can exacerbate conditions like asthma and raise the risk of cardiac arrest up to 70 percent. One study found that in California alone, PM 2.5 emissions from wildfires caused more than 50,000 premature deaths between 2008 and 2018.
Canadian ecosystems known as peatlands are especially good at holding onto toxicants like arsenic. These form in soggy places where wet plant matter resists decay, building up into layers of peat — basically concentrated carbon. Peat can accumulate over millennia, meaning it can also hold onto pollutants deposited there decades ago. 'The peat soils are landscape hot spots for metals,' said McCarter. 'When it's dry and hot — like we've been seeing with the weather over the prairie provinces and central and western Canada — the peatlands can really start to dry out. Then the fire is able to propagate and get hot enough to start releasing some of these metals.'
A peat fire behaves much weirder than a traditional forest fire. Instead of just burning horizontally across the landscape, a peat fire smolders down into the ground. This is a slow burn that lasts not just hours or days, but potentially months — releasing toxic metals and particulate matter as smoke all the while. Peat fires are so persistent that they'll sometimes start in the summer, get covered over with snow in the winter, and pop up once again in the spring melt. Scientists call them zombie fires.
As Canada's wildfire smoke creeps down into the US, it's also transforming. Chemical reactions between gases and sunlight create ozone, which further exacerbates lung conditions like asthma. 'Once you get six hours to a day or so downwind, the ozone formation inside smoke plumes can start being problematic,' said Rebecca Hornbrook, an atmospheric chemist at the NSF National Center for Atmospheric Research, who studies wildfire smoke.
People fleeing Canada's fires have to worry not just about losing their homes, but also losing their health. More than 40 percent of wildfire evacuations happen in communities that are predominantly Indigenous — an irony given that First Nations people know how to reduce the severity of these conflagrations, with traditional burning practices that more gently clear out the dead vegetation that acts as wildfire fuel. That strategy of prescribed burns, though, has only recently been making a comeback in Canada. 'Let's not forget that it's immediately affecting a lot of, in particular, First Nations communities in the northern parts of Manitoba, Alberta, and Saskatchewan,' said Waddington.
This haze is already bad for human health, and now there's the added potential for arsenic and other toxicants in the Canadian landscape to get caught up in wildfire smoke. 'It's a bad-news scenario,' Waddington said. 'It's quite scary.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CCRAN Announces Its Third Annual Pan-Tumour Biomarkers Conference: Transforming Cancer Care for Patients Through Precision Medicine, Policy, and Partnerships
CCRAN Announces Its Third Annual Pan-Tumour Biomarkers Conference: Transforming Cancer Care for Patients Through Precision Medicine, Policy, and Partnerships

Cision Canada

time38 minutes ago

  • Cision Canada

CCRAN Announces Its Third Annual Pan-Tumour Biomarkers Conference: Transforming Cancer Care for Patients Through Precision Medicine, Policy, and Partnerships

TORONTO, /CNW/ - The Colorectal Cancer Resource & Action Network (CCRAN) proudly announces its third annual Pan-Tumour Biomarkers Conference, taking place virtually June 19 - 20, 2025. As the role of comprehensive genomic profiling (CGP) and biomarker-driven treatments become increasingly vital in cancer care, this event reaffirms CCRAN's position at the forefront of Canada's precision medicine movement. The 2025 Conference arrives at a critical time. With provinces and territories working to align clinical innovation with system delivery, this year's event brings together leaders across healthcare, policy, research, industry, and patient communities to explore what it will take to embed comprehensive genomic profiling (CGP) into the fabric of cancer care - consistently, efficiently, and with long-term sustainability in mind. With a curated agenda centered on health system readiness, policy development and advocacy strategies, the Conference will drive widespread integration of genomic testing, specifically CGP, across cancer care in Canada. From laboratory infrastructure to funding models and clinical adoption, speakers will explore both the science and systems behind matching patients with the most effective treatments for their unique cancer profile. A key highlight of the 2025 Conference is the keynote presentation by the Conference Board of Canada, wherein a groundbreaking cost-benefit analysis will be unveiled to showcase the transformative value of CGP across five tumour types – lung, colorectal, breast, pancreatic and prostate. This study will demonstrate not only the substantial return on investment in modernizing Canada's testing landscape, but more importantly, quantify the profound benefits to patients, including improved survival outcomes, enhanced quality of life, reduced treatment toxicity, and faster access to targeted therapies. This critical data will inform policy decisions and provide compelling evidence for healthcare leaders to accelerate the adoption of precision medicine, ultimately ensuring Canadian cancer patients receive the most effective, personalized care possible. The event also builds on CCRAN's continued efforts to mobilize support for biomarker-driven cancer care through education, policy dialogue, and cross-sector partnerships. CCRAN has played a vital role in amplifying the urgency of public access to biomarker testing and is also helping to align national conversations around the need for timely, standardized, and publicly funded diagnostics. " Precision oncology must be accessible to every Canadian metastatic cancer patient, regardless of geography or circumstance," said Filomena Servidio-Italiano, President & CEO, CCRAN. " This Conference brings together the expertise and momentum required to overcome barriers and chart a clear path forward for advancing genomic testing in Canada's cancer care system." The Conference is designed for healthcare professionals, health system administrators, researchers, policy leaders, patients, caregivers, and all those invested in building a more personalized and equitable future for cancer care in Canada. CCRAN extends its heartfelt gratitude to our premier partners - Merck, AstraZeneca, Roche, Johnson & Johnson - for their unwavering commitment to advancing equitable access to precision medicine in Canada. The organization also expresses its sincere appreciation to the balance of the Conference sponsors as well as the dedicated patient advocacy group partners whose collaboration ensures that the patient voice remains at the heart of every initiative. Registration is free. All sessions will be hosted virtually and made available for post-event viewing. To register and view the full agenda, visit: About CCRAN: The Colorectal Cancer Resource & Action Network (CCRAN) is a national, patient-focused advocacy group that champions the health and well-being of Canadians touched by colorectal cancer, and others at risk of developing the disease. They provide support, education, and advocacy to patients (and their caregivers) to help improve patients' quality of life, as well as their longevity.

RADIATION SAFETY INSTITUTE OF CANADA HOSTS SAFETY PARTNER AWARENESS BREAKFAST TO MARK MILESTONE 45TH ANNIVERSARY
RADIATION SAFETY INSTITUTE OF CANADA HOSTS SAFETY PARTNER AWARENESS BREAKFAST TO MARK MILESTONE 45TH ANNIVERSARY

Cision Canada

time3 hours ago

  • Cision Canada

RADIATION SAFETY INSTITUTE OF CANADA HOSTS SAFETY PARTNER AWARENESS BREAKFAST TO MARK MILESTONE 45TH ANNIVERSARY

Radiation Safety Institute of Canada to host annual Radiation Safety Partner Awareness Breakfast The Institute was founded in 1980 as a response to Ontario's Elliot Lake disaster The Institute is a unique organization in Canada; it is the only independent-of-industry and government not-for-profit body solely dedicated to radiation safety TORONTO, June 12, 2025 /CNW/ - 2025 marks the Radiation Safety Institute of Canada 's 45th anniversary. The Institute is an independent, national organization dedicated to radiation safety. For over four decades, the Institute has served Canadians as a trusted national voice of scientific integrity, providing "Good Science in Plain Language"® answers to complex radiation-related issues. To mark the 45th anniversary, the Institute will host its annual Radiation Safety Partner Awareness Breakfast. This event will be held tomorrow on Friday, June 13, at 9:00 AM at Hart House on the University of Toronto 's St. George Campus. The breakfast reception will bring together key partners of the Institute from the province of Ontario and beyond. Note the in-person event is sold out but online registrants are still welcome. Click here to register as an online participant. Event details as follows: Guest of honour is Dr. Joel Moody, Ontario Chief Prevention Officer (CPO) and Assistant Deputy Minister, Ministry of Labour, Immigration, Training and Skills Development. Keynote speaker is Dr. Tanja Perko, Senior Researcher, Scientific Project Leader and Professor at the Belgian Nuclear Research Centre (SCK CEN) and at the University of Antwerp in Belgium. The meeting will introduce topics relevant to health and safety in every industry. With the help of Dr Tanja Perko, our keynote speaker, we shall explore the topic of risk communications and risk perception and as it relates to the safety conversation at large, new technologies and radiation safety, in particular. In the world of rapidly changing technologies, from Small Modular Reactors (SMRs) to hand-held X-Ray machines, the organization is steadfast in its commitment to provide Canadian workplaces, schools, and communities with independent radiation safety guidance based on quality scientific information and best practices. The Institute was founded in 1980 as a direct, independent response to the human disaster in the Elliot Lake uranium mines, where healthy miners had been exposed to excessive amounts of radon gas and radon progeny in the underground mining environment. Key quote: "The Radiation Safety Institute of Canada was established to ensure that a radiation disaster like or such as Elliot Lake mines never happens again. Back in the 1980s, the Institute's mission was to save lives, and we carry that proud legacy today. 45 years later, the Institute continues to honor its beginnings and serve uranium miners while providing a broad range of services to almost every industrial and societal sector in Canada." – Natalia Mozayani, President and CEO, Radiation Safety Institute of Canada.

Opinion: Exercise improves cancer survival — and a Canadian study leads the way
Opinion: Exercise improves cancer survival — and a Canadian study leads the way

Vancouver Sun

time16 hours ago

  • Vancouver Sun

Opinion: Exercise improves cancer survival — and a Canadian study leads the way

Last week, history was made in the world of cancer research — not with a new drug, but with something far more accessible and powerful: exercise. A landmark study published in The New England Journal of Medicine has confirmed, for the first time in a randomized controlled trial, that a structured exercise program can significantly improve survival for people treated for early-stage colon cancer. The Challenge trial showed that a three-year structured exercise program initiated after chemotherapy reduced the risk of cancer recurrence or death by 28 per cent, and improved overall survival by 37 per cent. Compared to health education alone, this was a 7.1 per cent improvement in the likelihood of being alive at the eight-year mark. Let that sink in: Brisk walking a few times a week can improve survival as much — or more — than many modern cancer drugs, with none of the side effects and at a fraction of the cost. A daily roundup of Opinion pieces from the Sun and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Informed Opinion will soon be in your inbox. Please try again Interested in more newsletters? Browse here. For years, observational studies hinted that physically active cancer survivors tended to live longer and feel better. But these studies were limited by their design — confounded by the fact that healthier people might be more likely to exercise. Now, the Challenge trial provides the gold-standard evidence we've been waiting for — led by Drs. Christopher Booth and Kerry Courneya through the Canadian Cancer Trials Group, this 'first-in-class' trial enrolled 889 patients in Canada, Australia, and the UK and confirmed that supervised exercise with behaviour change support improves both disease-free and overall survival, while enhancing physical functioning and quality of life. This has profound implications for cancer care — and for our health system. First, it's time to redefine 'treatment.' Cancer care has long focused on surgery, chemotherapy, and radiation. But what happens after treatment is often an afterthought. Survivors may be left with side effects, fatigue, and fear of recurrence, and limited resources to support them. The Challenge trial flips that paradigm: recovery isn't passive. Exercise is not a 'nice to have' — it is a powerful, life-prolonging intervention. Second, access to structured exercise programs are not currently a standard-of-care for cancer survivors in Canada. That must change. These programs require relatively modest investment compared to the high costs of systemic therapies — yet they deliver survival benefits on par with expensive drugs. And unlike drugs, exercise can also reduce cardiovascular risk, improve mental health, and enhance overall quality of life. Third, this is a Canadian success story. The Challenge trial was conceived, led, and executed by Canadian investigators. The Canadian Cancer Society, together with global partners, funded this 15-year effort — a testament to the power of sustained investment in publicly funded clinical research. At a time when Canada's health research ecosystem faces financial strain, the success of Challenge highlights what's possible when we back bold ideas with the resources they deserve. Finally, the findings call on all of us — policymakers, cancer agencies and clinicians — to act. We must embed exercise into survivorship care across the country and simply telling people to exercise is not enough. This will require funding to support exercise professionals in cancer centres and the community, build incentives for survivor-focused programming, and eliminate structural barriers to participation. Survivorship care is not optional — it's essential. Of course, exercise is not a cure-all. Some patients may be unable to participate due to comorbidities or limitations. But for the majority, supervised aerobic activity like walking or cycling can and should be part of the care plan. Importantly, the Challenge program was designed to be adaptable and accessible — guided by behavioural science, delivered by trained consultants, and tailored to each patient's fitness level. We should applaud the Challenge investigators, the Canadian Cancer Trials Group, and the hundreds of patients who participated in this transformative trial. Their commitment will change how we support people after cancer — not just in Canada, but around the world. Now, it's our turn to rise to the challenge. Dr. Sharlene Gill is a medical oncologist at B.C. Cancer, professor of medicine at the University of B.C., and chair of the GI Disease Site for the Canadian Cancer Trials Group.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store